Citadel Advisors’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.4M | Buy |
1,231,126
+524,462
| +74% | +$12.1M | ﹤0.01% | 771 |
|
|
2025
Q1 | $19.1M | Sell |
706,664
-654,214
| -48% | -$17.7M | ﹤0.01% | 917 |
|
|
2024
Q4 | $72.9M | Buy |
1,360,878
+351,110
| +35% | +$18.8M | 0.01% | 378 |
|
|
2024
Q3 | $45.9M | Sell |
1,009,768
-547,348
| -35% | -$24.9M | 0.01% | 515 |
|
|
2024
Q2 | $65.2M | Sell |
1,557,116
-793,122
| -34% | -$33.2M | 0.01% | 380 |
|
|
2024
Q1 | $88.5M | Sell |
2,350,238
-769,967
| -25% | -$29M | 0.02% | 282 |
|
|
2023
Q4 | $33.5M | Sell |
3,120,205
-311,004
| -9% | -$3.34M | 0.01% | 631 |
|
|
2023
Q3 | $34.6M | Buy |
3,431,209
+1,315,635
| +62% | +$13.3M | 0.01% | 570 |
|
|
2023
Q2 | $25.1M | Buy |
2,115,574
+262,548
| +14% | +$3.12M | 0.01% | 713 |
|
|
2023
Q1 | $22.4M | Sell |
1,853,026
-1,785
| -0.1% | -$21.6K | ﹤0.01% | 801 |
|
|
2022
Q4 | $24.4M | Buy |
1,854,811
+1,595
| +0.1% | +$21K | 0.01% | 763 |
|
|
2022
Q3 | $25.1M | Sell |
1,853,216
-216
| -0% | -$2.93K | 0.01% | 700 |
|
|
2022
Q2 | $22.6M | Hold |
1,853,432
| – | – | 0.01% | 763 |
|
|
2022
Q1 | $26.6M | Hold |
1,853,432
| – | – | 0.01% | 736 |
|
|
2021
Q4 | $36.6M | Sell |
1,853,432
-5,814
| -0.3% | -$115K | 0.01% | 630 |
|
|
2021
Q3 | $39.6M | Sell |
1,859,246
-27,466
| -1% | -$586K | 0.01% | 552 |
|
|
2021
Q2 | $46.2M | Buy |
+1,886,712
| New | +$46.2M | 0.01% | 529 |
|